Greenwich LifeSciences (GLSI) Stock Chart & Stock Price History $12.08 +0.42 (+3.56%) As of 09:47 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Greenwich LifeSciences Stock Price Performance The Greenwich LifeSciences (GLSI) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 12.74%, with a year-to-date return of 7.61%. In the past month, the stock has increased 19.77%, reflecting recent market activity. As of the latest close, Greenwich LifeSciences traded at $11.67 with a market cap of $156.01 million and volume of 81,083 shares. Receive GLSI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Greenwich LifeSciences and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+8.97%1 Month Performance+19.77%3 Month Performance+25.43%Year-To-Date Performance+7.61%1 Year Performance-12.74% GLSI Stock Chart for Friday, August, 8, 2025 GLSI Chart by TradingView Greenwich LifeSciences Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/07/2025$12.10$11.67-3.55%$12.30$11.4481,083 shs$156.01 million08/06/2025$11.72$12.10+3.24%$12.21$11.5126,619 shs$161.78 million08/05/2025$11.94$11.72-1.84%$12.00$11.5717,107 shs$156.70 million08/04/2025$11.09$11.94+7.66%$11.94$11.1038,473 shs$159.61 million08/01/2025$10.94$11.09+1.37%$11.29$10.7045,636 shs$148.25 million07/31/2025$11.25$10.94-2.76%$11.51$10.9425,616 shs$146.27 million07/30/2025$11.13$11.25+1.08%$11.73$11.0648,798 shs$150.41 million07/29/2025$11.55$11.13-3.64%$11.72$11.0715,760 shs$148.79 million07/28/2025$11.57$11.55-0.17%$11.71$11.3421,166 shs$154.42 million07/25/2025$11.49$11.57+0.70%$11.74$11.1637,274 shs$154.69 million Get the Latest News and Ratings for GLSI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Greenwich LifeSciences and its competitors with MarketBeat's FREE daily newsletter. 07/24/2025$11.49$11.49$11.64$11.3230,249 shs$153.62 million07/23/2025$11.14$11.49+3.14%$11.64$11.1665,766 shs$153.60 million07/22/2025$11.76$11.14-5.27%$11.96$11.06104,167 shs$148.94 million07/21/2025$11.59$11.76+1.47%$12.32$11.50159,885 shs$157.23 million07/18/2025$12.30$11.59-5.77%$12.49$11.55154,544 shs$154.96 million07/17/2025$11.19$12.30+9.92%$12.54$11.10218,350 shs$164.45 million07/16/2025$10.08$11.19+11.01%$11.19$10.01174,844 shs$149.59 million07/15/2025$10.81$10.08-6.75%$10.81$10.00163,119 shs$134.77 million07/14/2025$10.84$10.81-0.28%$10.92$10.1388,735 shs$144.53 million07/11/2025$11.22$10.84-3.39%$11.52$10.7560,219 shs$144.93 million07/10/2025$10.55$11.22+6.35%$11.29$10.4572,635 shs$149.99 million07/09/2025$10.09$10.55+4.56%$10.58$10.0535,299 shs$141.05 million07/08/2025$10.07$10.09+0.20%$10.21$10.0433,144 shs$134.90 million07/07/2025$10.04$10.07+0.35%$10.32$9.9036,195 shs$134.64 million Related Companies REPL Stock Chart EOLS Stock Chart PHAT Stock Chart KROS Stock Chart RLAY Stock Chart BCAX Stock Chart TLRY Stock Chart ORGO Stock Chart XNCR Stock Chart MRVI Stock Chart Receive GLSI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Greenwich LifeSciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GLSI) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Greenwich LifeSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Greenwich LifeSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
